Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years

There are limited data concerning the immunogenicity and reactogenicity of COVID-19 vaccines in children. A total of 110 children, 5–11 years old were vaccinated with two doses (with a 3-week interval between doses) of the Pfizer-BioNTech COVID-19 vaccine and were followed for 21, 90, and 180 days a...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Gili, Klein, Elisheva, Lustig, Yaniv, Weiss-Ottolenghi, Yael, Asraf, Keren, Indenbaum, Victoria, Amit, Sharon, Kriger, Or, Gilboa, Mayan, Levy, Yuval, Pessach, Itai M., Kreiss, Yitshak, Regev-Yochay, Gili, Stein, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693260/
https://www.ncbi.nlm.nih.gov/pubmed/36423049
http://dx.doi.org/10.3390/vaccines10111954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693260/
https://www.ncbi.nlm.nih.gov/pubmed/36423049
http://dx.doi.org/10.3390/vaccines10111954

Ejemplares similares